Steven F. Dowdy
Corporate Officer/Principal chez University of California San Diego
Profil
Steven F.
Dowdy was the founder of Solstice Biologics LLC (founded in 2012) and Traversa Therapeutics, Inc. (founded in 2006), where he held the title of Director and Chief Scientific Officer, respectively.
Currently, he is a Professor at the University of California San Diego.
He received his doctorate degree from the University of California, Irvine.
Postes actifs de Steven F. Dowdy
Sociétés | Poste | Début |
---|---|---|
University of California San Diego | Corporate Officer/Principal | - |
Anciens postes connus de Steven F. Dowdy
Sociétés | Poste | Fin |
---|---|---|
Traversa Therapeutics, Inc.
Traversa Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Traversa Therapeutics, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of RNAi Delivery Technologies. The Company strives to rapidly advance short interfering RNA (siRNA) platform delivery technologies for use by RNAi therapeutic companies in targeting a wide variety of acute, chronic and infectious human diseases. Traversa is focused on the optimization of this platform delivery technology, as well as advancement of its own therapeutic programs for the treatment of Leukemia and Glioblastoma. The Company was founded in La Jolla, California in mid-2006, and has secured worldwide exclusive licenses to intellectual property developed during the past five years by Steven F. Dowdy, Ph.D., and his research group at the Howard Hughes Medical Institute and the University of California San Diego relating to siRNA delivery technology and induction of RNA Interference (RNAi). | Fondateur | 19/12/2012 |
Solstice Biologics LLC
Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Solstice Biologics LLC develops nucleic acid therapeutics. It specializes in the development of small, cell-permeable RNAi pro-drugs. The company was founded by Steven Dowdy and Curt W. Bradshaw in 2012 and is headquartered in San Diego, CA. | Fondateur | - |
Formation de Steven F. Dowdy
University of California, Irvine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Traversa Therapeutics, Inc.
Traversa Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Traversa Therapeutics, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of RNAi Delivery Technologies. The Company strives to rapidly advance short interfering RNA (siRNA) platform delivery technologies for use by RNAi therapeutic companies in targeting a wide variety of acute, chronic and infectious human diseases. Traversa is focused on the optimization of this platform delivery technology, as well as advancement of its own therapeutic programs for the treatment of Leukemia and Glioblastoma. The Company was founded in La Jolla, California in mid-2006, and has secured worldwide exclusive licenses to intellectual property developed during the past five years by Steven F. Dowdy, Ph.D., and his research group at the Howard Hughes Medical Institute and the University of California San Diego relating to siRNA delivery technology and induction of RNA Interference (RNAi). | Commercial Services |
Solstice Biologics LLC
Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Solstice Biologics LLC develops nucleic acid therapeutics. It specializes in the development of small, cell-permeable RNAi pro-drugs. The company was founded by Steven Dowdy and Curt W. Bradshaw in 2012 and is headquartered in San Diego, CA. | Health Technology |